Multiple Organ Dysfunction Syndrome Clinical Trial
Official title:
Clinical Trial to Assess the Tolerance and the Safety of a Duodenal Tube Monitoring the Microcirculation in 10 Critically Ill Patients.
For Intensive Care Units (ICU) patients, Multiple Organ Dysfunction Syndrome (MODS) is a
very common complication yielding high morbidity and mortality. Inadequate regional
perfusion of certain organs (gut, kidney, liver, etc) often caused by shock is the main
cause of MODS. Current practice uses cardiac output data and blood pressure to manage shock
but there are still lacks of information about the regional perfusion. This leads to late
MODS diagnostics preventing the implementation of adequate treatment.
Gut perfusion monitoring seems to be a good target to assess the microcirculation but,
nowadays, no practical methods or devices are available to measure the gut perfusion, and
the current monitoring methods are not specific (CO, BP, OPS-SDF, PCO2, etc).
"MC Monitor" trial is a prospective, multi-center pilot study, enrolling 10 patients.
The probe will be used by intensivists on ICU patients with a risk of shock and requiring
mechanical ventilation.
The probe will be placed in the patient with an endoscopic procedure by a gastroenterologist
(standard procedure for post-pyloric tubes placement). This procedure will be used to assess
the status of the gut mucosa prior to the placement of the APD probe.
n/a
Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT00430859 -
Bovine Intestinal Alkaline Phosphatase for the Treatment of Patients With Sepsis
|
Phase 2 | |
| Recruiting |
NCT01713205 -
Prediction Study of Complications After Severe Trauma
|
||
| Recruiting |
NCT01186783 -
Reducing Elevated Heart Rate in Patients With Multiple Organ Dysfunction Syndrome (MODS) by Ivabradine
|
Phase 2 | |
| Terminated |
NCT03489577 -
The Role of Post-traumatic Inhibition of the Innate and Adaptive Immune System in the Development of Infectious Complications in Severely Injured Patients
|
||
| Completed |
NCT04438460 -
Pediatric Immune Response to Multi-Organ Dysfunction
|
N/A | |
| Recruiting |
NCT00908635 -
The Role of Angiopoietin, Tie-2, and Vascular Endothelial Growth Factor (VEGF) in Sepsis-Induced Multiple Organ Dysfunction Syndrome (MODS)
|
N/A | |
| Recruiting |
NCT04014413 -
Safety and Efficacy of Fecal Microbiota Transplantation
|
N/A | |
| Recruiting |
NCT03552848 -
Mesenchymal Stem Cells for Multiple Organ Dysfuntion Syndrome After Surgical Repaire of Acute Type A Aortic Dissection
|
N/A | |
| Enrolling by invitation |
NCT02204215 -
Electric Acupuncture for ICU-acquired Weakness in Mechanical Ventilation Patients
|
N/A | |
| Recruiting |
NCT01802983 -
The Prognostic Assessment of Extubation in Aged Patients With Multiple Organ Dysfunction Syndrome
|
N/A | |
| Completed |
NCT03019250 -
A Trial of Enteral Colostrum on Clinical Outcomes in Critically Ill Patients
|
N/A | |
| Terminated |
NCT01787045 -
Early Physical Therapy in Patients With Sepsis
|
N/A | |
| Completed |
NCT03518203 -
Eculizumab to Treat Thrombotic Microangiopathy/Atypical Hemolytic Uremic Syndrome -Associated Multiple Organ Dysfunction Syndrome in Hematopoietic Stem Cell Transplant Recipients
|
Phase 2 | |
| Completed |
NCT00736723 -
NT-proBNP in ICU Postoperative/Posttraumatic Patients With Shock
|
N/A | |
| Completed |
NCT00736827 -
BK Virus and Renal Dysfunction in Postoperative/Posttraumatic Critically Ill Patients
|
N/A | |
| Recruiting |
NCT00127985 -
6-Methyl-Prednisolone for Multiple Organ Dysfunction Syndrome
|
Phase 4 | |
| Recruiting |
NCT03589378 -
Therapeutic Plasma Exchange Adsorption Diafiltration
|
N/A | |
| Terminated |
NCT01275976 -
Effect of C1-esterase Inhibitor on Systemic Inflammation in Trauma Patients With a Femur or Pelvic Fracture
|
Phase 3 |